Western Australia invests $4 million in biomedical hub

The Western Australian government announced on 19 November 2026 that it will provide $4 million in total funding to the WA Life Sciences Innovation Hub (WALSIH) over the next four years. This financial commitment of $1 million per annum is designed to sustain the hub’s operations and support the ongoing expansion of the state’s biomedical industry.
How does this funding impact local biomedical businesses?
The investment ensures that WALSIH can continue offering its specialized concierge services to local innovators and companies. These services are intended to assist businesses in commercializing new medical technologies, securing necessary capital, and navigating entry into both national and global markets. By acting as a central connector, the hub links the health and medical life sciences sector with essential networks, providing access to commercial partnerships and technical expertise.
Since its establishment through a collaboration between the state government, The University of Western Australia, and AUScelerate, the hub has functioned as a cornerstone of the regional innovation ecosystem. Over the past eight years, the organization has supported more than 129 companies through over 1,240 individual consultations. These efforts have focused on enhancing commercial capability and preparing firms for investment. Furthermore, the hub has facilitated the training of 149 graduates through the Perth Biodesign Flagship and iPREP programs since 2023.
The financial impact of these efforts is measurable, with the hub having supported 178 grant applications that resulted in more than $63.3 million in non-dilutive funding for local organizations. Science and Innovation and Medical Research Minister Stephen Dawson noted that the hub serves as a primary driver for job creation and investment within the state.
What is the broader strategy for innovation in Western Australia?
WALSIH represents one of six existing innovation hubs in Western Australia, which also include sectors such as cyber security, data science, green tech, food tech, and creative tech. The government is currently expanding this network by initiating an open expression of interest process to establish a seventh hub focused on commercialization.
The continued support for WALSIH is part of a broader government strategy to position Western Australia as a leader in the life sciences sector. By maintaining these specialized hubs, the state aims to provide a structured environment where emerging businesses can access the resources required to scale their operations. The government expects that this sustained investment will ensure the biomedical sector remains a key contributor to the state’s economic growth and innovation output. Future developments will depend on the outcomes of the current expression of interest process for the new commercialization hub and the ongoing performance of the existing six centers.